IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+11.95%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
(+36%)
Cap. Flow
+$7.51M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
132
New
23
Increased
7
Reduced
12
Closed
26
Top Buys
| 1 |
argenx
ARGX
|
$26.5M |
| 2 |
SPDR S&P Homebuilders ETF
XHB
|
$19.1M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
$12.9M |
| 4 |
Sarepta Therapeutics
SRPT
|
$12.8M |
| 5 |
Annexon
ANNX
|
$12M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$45.7M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$12.4M |
| 3 |
Akero Therapeutics
AKRO
|
$10.1M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$8.89M |
| 5 |
Vaxcyte
PCVX
|
$7.26M |
Sector Composition
| 1 | Healthcare | 92.55% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Corcept Therapeutics
CORT
$7.6B
| – | – |
0
| – | – |
|
127
89bio
ETNB
$1.37B
| – | – |
0
| – | – |
|
128
FibroGen
FGEN
$49.3M
| – | – |
-2,774
| Closed | -$2.39K |
|
129
Foghorn Therapeutics
FHTX
$306M
| – | – |
-15,292
| Closed | -$76.5K |
|
130
IDEAYA Biosciences
IDYA
$2.26B
| – | – |
-216,949
| Closed | -$5.85M |
|
131
Immunic
IMUX
$79.3M
| – | – |
-450,000
| Closed | -$662K |
|
132
Insmed
INSM
$30.6B
| – | – |
-154,900
| Closed | -$3.91M |
|